A
24.32
-0.82 (-3.28%)
| Previous Close | 25.14 |
| Open | 25.10 |
| Volume | 478,790 |
| Avg. Volume (3M) | 3,663,388 |
| Market Cap | 2,242,129,408 |
| Price / Earnings (Forward) | 13.14 |
| Price / Sales | 0.660 |
| Price / Book | 1.14 |
| 52 Weeks Range | |
| Earnings Date | 11 May 2026 |
| Profit Margin | 5.94% |
| Operating Margin (TTM) | 10.19% |
| Diluted EPS (TTM) | 2.04 |
| Quarterly Revenue Growth (YOY) | 0.30% |
| Quarterly Earnings Growth (YOY) | -89.00% |
| Total Debt/Equity (MRQ) | 74.09% |
| Current Ratio (MRQ) | 1.35 |
| Operating Cash Flow (TTM) | 462.46 M |
| Levered Free Cash Flow (TTM) | -276.20 M |
| Return on Assets (TTM) | 5.06% |
| Return on Equity (TTM) | 6.33% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Bullish | Mixed |
| Medical Care Facilities (Global) | Bullish | Bullish | |
| Stock | Acadia Healthcare Company, Inc. | Bullish | Bearish |
AIStockmoo Score
-0.9
| Analyst Consensus | -1.5 |
| Insider Activity | -3.0 |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 2.0 |
| Average | -0.90 |
|
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Value |
| % Held by Insiders | 1.75% |
| % Held by Institutions | 109.93% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Khrom Capital Management Llc | 31 Dec 2025 | 7,351,034 |
| Abrams Bison Investments, Llc | 31 Dec 2025 | 4,380,000 |
| Dme Capital Management, Lp | 31 Dec 2025 | 4,121,203 |
| Invenomic Capital Management Lp | 31 Dec 2025 | 3,312,043 |
| Hawk Ridge Capital Management Lp | 31 Dec 2025 | 2,379,097 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 28.00 (RBC Capital, 15.16%) | Buy |
| Median | 22.00 (-9.52%) | |
| Low | 15.00 (Jefferies, -38.31%) | Hold |
| Average | 21.88 (-10.01%) | |
| Total | 4 Buy, 4 Hold | |
| Avg. Price @ Call | 19.89 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Barclays | 03 Mar 2026 | 20.00 (-17.75%) | Hold | 22.99 |
| Leerink Partners | 26 Feb 2026 | 22.00 (-9.52%) | Hold | 22.29 |
| RBC Capital | 26 Feb 2026 | 28.00 (15.16%) | Buy | 22.29 |
| 14 Jan 2026 | 17.00 (-30.08%) | Buy | 11.73 | |
| TD Cowen | 26 Feb 2026 | 24.00 (-1.30%) | Buy | 22.29 |
| 16 Jan 2026 | 22.00 (-9.52%) | Buy | 11.68 | |
| UBS | 26 Feb 2026 | 27.00 (11.04%) | Buy | 22.29 |
| Guggenheim | 23 Feb 2026 | 22.00 (-9.52%) | Buy | 17.38 |
| Jefferies | 22 Jan 2026 | 15.00 (-38.31%) | Hold | 15.15 |
| Mizuho | 18 Dec 2025 | 17.00 (-30.08%) | Hold | 14.43 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 04 Feb 2026 | Announcement | Acadia Healthcare Announces Date for Fourth Quarter and Year-End 2025 Earnings Release |
| 20 Jan 2026 | Announcement | Acadia Healthcare Appoints Debbie Osteen as Chief Executive Officer |
| 06 Jan 2026 | Announcement | Acadia Healthcare to Participate in 44th Annual J.P. Morgan Healthcare Conference |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |